269 reports of this reaction
1.8% of all BENAZEPRIL HYDROCHLORIDE reports
#11 most reported adverse reaction
ASTHENIA is the #11 most commonly reported adverse reaction for BENAZEPRIL HYDROCHLORIDE, manufactured by Validus Pharmaceuticals LLC. There are 269 FDA adverse event reports linking BENAZEPRIL HYDROCHLORIDE to ASTHENIA. This represents approximately 1.8% of all 15,362 adverse event reports for this drug.
Patients taking BENAZEPRIL HYDROCHLORIDE who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENIA is a less commonly reported adverse event for BENAZEPRIL HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to asthenia, the following adverse reactions have been reported for BENAZEPRIL HYDROCHLORIDE:
The following drugs have also been linked to asthenia in FDA adverse event reports:
ASTHENIA has been reported as an adverse event in 269 FDA reports for BENAZEPRIL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENIA accounts for approximately 1.8% of all adverse event reports for BENAZEPRIL HYDROCHLORIDE, making it a notable side effect.
If you experience asthenia while taking BENAZEPRIL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.